Olfatifar, M.; Asadzadeh Aghdaei, H.; Hasanpour Dehkordi, A.; Shahrokh, S.; Pourhoseingholi, M.A.; Balaii, H.; Mohsen Rajabnia, M.; Ivanchuk, Maria; Ivanchuk, Pavlo; Hashemi Nazari, S.; Sabour, S.; Rohani, P.; Mehralian, G.; Khodakarim, S.; Hatami, B.; Malekpour, H.; Sherkat, G.; Zali, M.R.; Rahimi Pordanjani, S.
(Immunopathologia Persa (міжнародний рецензований журнал), 2023)
Objectives: This study was done to evaluate the cost-effectiveness of IFX versus CinnoRA for the treatment of moderate-to-severe UC patients. Conclusion: Our results demonstrated that IFX is more effective and more costly ...